fbpx Back to Top

Homozygous Familial Hypercholesterolemia Premium

Get Help with Your Treatment

Apply Online or call 1-866-316-7263


Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.


For current information, log in toFundFinder.

Assistance Amount

$4,500 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.


Premium Assistance Information

Eligibility Criteria

  1. The patient must be getting treatment for homozygous familial hypercholesterolemia.
  2. The patient must have health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Altoprev (lovastatin)
  • Atorvastatin Calcium (atorvastatin calcium)
  • Crestor (rosuvastatin calcium)
  • Ezallor Sprinkle (rosuvastatin calcium)
  • Ezetimibe-simvastatin (ezetimibe/simvastatin)
  • Fluvastatin Sodium (fluvastatin sodium)
  • Juxtapid (lomitapide mesylate)
  • Kynamro (mipomersen sodium)
  • Lescol (fluvastatin sodium)
  • Lipitor (atorvastatin calcium)
  • Livalo (pitavastatin calcium)
  • Lovastatin (lovastatin)
  • Pravachol (pravastatin sodium)
  • Pravastatin Sodium (pravastatin sodium)
  • Repatha Pushtronex (evolocumab)
  • Repatha Sureclick (evolocumab)
  • Repatha Syringe (evolocumab)
  • Rosuvastatin Calcium (rosuvastatin calcium)
  • Simvastatin (simvastatin)
  • Vytorin (ezetimibe/simvastatin)
  • Zetia (ezetimibe)
  • Zocor (simvastatin)
  • Zypitamag (pitavastatin magnesium)

Diagnosis Codes:

ICD-10: E78.01


About the Disease:

Homozygous familial hypercholesterolemia (FH), also known as familial hypercholesterolemia, is a genetic disease characterized by high low-density lipoprotein cholesterol levels. FH is a rare disease that affects the circulatory system.


Source: National Institutes of Health